These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29762783)

  • 1. Repurposing the anthelminthic salicylanilide oxyclozanide against susceptible and clinical resistant Candida albicans strains.
    Pic E; Burgain A; Sellam A
    Med Mycol; 2019 Apr; 57(3):387-390. PubMed ID: 29762783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.
    Rajamuthiah R; Fuchs BB; Conery AL; Kim W; Jayamani E; Kwon B; Ausubel FM; Mylonakis E
    PLoS One; 2015; 10(4):e0124595. PubMed ID: 25897961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi.
    Wiederhold NP; Patterson TF; Srinivasan A; Chaturvedi AK; Fothergill AW; Wormley FL; Ramasubramanian AK; Lopez-Ribot JL
    Virulence; 2017 Feb; 8(2):138-142. PubMed ID: 27268469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro antibacterial activity of the anthelmintic drug oxyclozanide against common small animal bacterial pathogens.
    Levinson MR; Blondeau JM; Rosenkrantz WS; Plowgian CB
    Vet Dermatol; 2019 Aug; 30(4):314-e87. PubMed ID: 31062461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Haploid Model of
    Truong T; Suriyanarayanan T; Zeng G; Le TD; Liu L; Li J; Tong C; Wang Y; Seneviratne CJ
    Front Cell Infect Microbiol; 2018; 8():164. PubMed ID: 29938200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Holotoxin A
    Liao M; Xia X; Meng Q; Zhu C; Liao B; Wang J; Gou L; Zhou X; Yuan W; Cheng L; Ren B
    Br J Pharmacol; 2024 Jun; 181(12):1857-1873. PubMed ID: 38382564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
    Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
    Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-amino-nonyl-6-methoxyl-tetralin muriate activity against Candida albicans augments endogenous reactive oxygen species production --a microarray analysis study.
    Liang RM; Yong XL; Jiang YP; Tan YH; Dai BD; Wang SH; Hu TT; Chen X; Li N; Dong ZH; Huang XC; Chen J; Cao YB; Jiang YY
    FEBS J; 2011 Apr; 278(7):1075-85. PubMed ID: 21251230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
    Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
    J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study.
    Rana R; Sharma R; Kumar A
    Curr Mol Med; 2019; 19(7):506-524. PubMed ID: 31109273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of respiratory drug theophylline against Candida albicans: mechanistic insights unveil alterations in membrane properties and metabolic fitness.
    Singh S; Fatima Z; Ahmad K; Hameed S
    J Appl Microbiol; 2020 Oct; 129(4):860-875. PubMed ID: 32320111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans.
    Ng SMS; Yap JM; Lau QY; Ng FM; Ong EHQ; Barkham T; Teo JWP; Alfatah M; Kong KW; Hoon S; Arumugam P; Hill J; Brian Chia CS
    Eur J Med Chem; 2018 Apr; 150():479-490. PubMed ID: 29549835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.
    Chen T; Yao J; Quan K; Xu J; Hang X; Tong Q; Liu G; Luo P; Zeng L; Feng G; Bi H
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0113123. PubMed ID: 38018962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.